SAN DIEGO--(BUSINESS WIRE)--Verogen Inc. announced today that it is debuting an affordable entry point to NGS on the MiSeq FGx ® Sequencing System with the commercial launch of the ForenSeq MainstAY ...
QIAGEN N.V. QGEN recently announced that its ForenSeq MainstAY workflow for the U.S. National DNA Index System (“NDIS”) received FBI approval. Licenced forensic DNA laboratories will be able to ...
Revvity, Inc. RVTY recently collaborated with Element Biosciences, Inc. The tie-up is aimed at introducing workflow solutions that can save the time and effort needed for the genomic analysis of ...
ST. LOUIS--(BUSINESS WIRE)--Pierian®, a global leader in advanced clinical genomics technology and services, is pleased to announce an exciting partnership with P4 Diagnostix®, a leading-edge network ...
Next-generation sequencing (NGS) is quickly becoming the go-to tool for testing labs looking to bring on additional tests requiring smaller tissue samples, reduced time to results, and increased ...
The Association for Molecular Pathology (AMP), the premier global, non-profit molecular diagnostics professional society, today published consensus recommendations to help clinical laboratory ...
As next-generation sequencing (NGS) makes genetic testing for a wide range of human diseases increasingly commonplace, facile methods for validating the efficacy of those tests are essential. Federal ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic implications. Although few question ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results